483
Niagara Pharmaceuticals IncNiagara Pharmaceuticals Inc – FDA 483, Apr 25, 2022
Record Details
Niagara Pharmaceuticals Inc, a manufacturer in Dundas, was inspected by the FDA, resulting in four observations. The inspection revealed deficiencies in quality control unit procedures, vendor qualification, sampling criteria for packaging materials, manufacturing process validation, and the determination of actual and theoretical yields. These issues indicate a need for improved adherence to Good Manufacturing Practices.
View Company Profile
ID · c0f994c8-b70b-45a1-aaa0-ee60bd718b76
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.